NovoCure Limited Recorded Big Gain
Tue, Apr 13, 2021 at 05:33 PM
NovoCure Limited (NVCR:NASDAQ) shot up at $197.33, a gain of 49.6%. The stock appeared on our News Catalysts scanner on Tue, Apr 13, 2021 at 02:37 PM in the 'BIOTECH' category. From Mon, Mar 29, 2021, the stock recorded 55.56% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About NovoCure Limited (NVCR:NASDAQ)
NovoCure Ltd is a medical systems developer in the United States. Its primary product is the TTFields delivery system, which is a low-intensity therapy to combat acute tumors.
Top 10 Gainers:
- Mackinac Financial Corporation (MFNC:NASDAQ), 60.67%
- NovoCure Limited (NVCR:NASDAQ), 49.63%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 33.85%
- AHLD (AHLD:NYSE), 31.67%
- China Green Agriculture, Inc. (CGA:NYSE), 27.72%
- Ballantyne Strong, Inc (BTN:NYSEMKT), 24.69%
- PLBY (PLBY:NASDAQ), 23.01%
- Zai Lab Limited (ZLAB:NASDAQ), 22.14%
- Digimarc Corporation (DMRC:NASDAQ), 21.92%
- Biophytis SA (BPTS:NASDAQ), 21.43%